Background: Diabetes mellitus has emerged as a global health crisis, with its prevalence escalating dramatically. Diabetic peripheral neuropathy (DPN) stands out as one of the most frequent complications, leading to significant morbidity, including foot ulcers and amputations, if not identified and managed promptly. Effective screening methods are essential for early detection, which can significantly improve patient outcomes and reduce the risk of severe complications.
Aim And Objectives: This study aims to evaluate the sensitivity and specificity of the Diabetic Neuropathy Examination (DNE) score in comparison to the vibration perception threshold (VPT) test. Both methods will be assessed individually and in combination to determine their effectiveness in diagnosing DPN among patients with diabetes. The study also seeks to establish a correlation between these screening tests.
Materials And Methods: A case-control study was conducted involving 100 subjects, comprising 50 patients diagnosed with DPN and 50 healthy controls. The participants were aged between 30 and 70 years, and various parameters such as fasting blood sugar, anthropometric measurements, DNE scores, and VPT readings were recorded. Ethical clearance was obtained, and informed consent was secured from all participants.
Results: The findings indicated that the DNE score demonstrated a sensitivity of 80% and a specificity of 73.33%, while VPT exhibited a sensitivity of 70% and a specificity of 86.67%. When both tests were combined, the sensitivity increased to 90%, highlighting the potential for enhanced diagnostic accuracy through a multimodal approach.
Conclusion: The DNE score, when utilized alongside VPT, provides a robust framework for the early detection of DPN, particularly in community settings where resources may be limited. This study underscores the importance of integrating simple, effective screening techniques into routine clinical practice to mitigate the risks associated with diabetic complications.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11888648 | PMC |
| http://dx.doi.org/10.4103/jpbs.jpbs_1160_24 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Vitamin D receptor FokI polymorphism as a risk factor for painful diabetic neuropathy in type 2 diabetes mellitus patients.
J Neurogenet
March 2025
Department of Neurology, Faculty of Medicine, Universitas Udayana/Ngoerah Hospital, Bali, Indonesia.
Painful diabetic neuropathy (PDN) is a common complication in patients with type 2 diabetes mellitus (T2DM) with disruption of vitamin D (VD) activity as one of the risk factors. Active VD exerts its biological functions through the vitamin D receptor (VDR), which polymorphisms in the VDR gene can impair. This study aims to establish VDR FokI and ApaI polymorphisms as risk factors for PDN.
View Article and Find Full Text PDFMacromolecular Crowding Supports the Generation of Basal Membrane-Rich Pericyte-Based Cell Sheets Useful for Cell Therapy of Diabetic Wounds.
Cell Transplant
March 2025
Cardiovascular Research Unit, IRCCS MultiMedica, Milan, Italy.
Diabetic foot ulcers (DFUs) are associated with a high risk of amputations and a 50% 5-year survival rate due at least in part to the limited angiogenic and wound healing capacity of patients with diabetes. Cell therapy via intramuscular injection of peripheral blood mononuclear cells showed encouraging but limited results. Such limitations may arise from the limited ability of therapeutic cells to adhere to the target tissue.
View Article and Find Full Text PDFThe role of periodontal treatment on the reduction of hemoglobinA1c, comparing with existing medication therapy: a systematic review and meta-analysis.
Front Clin Diabetes Healthc
February 2025
Section of Geriatric Dentistry, Department of General Dentistry, Fukuoka Dental College, Fukuoka, Japan.
Background: Diabetes mellitus (DM) is linked to complications such as retinopathy, nephropathy, neuropathy, and cardiovascular disease, impacting patient quality of life and increasing healthcare costs. Periodontal disease, more prevalent in diabetic patients, is associated with worsened glycemic control and systemic inflammation, suggesting a possible bidirectional relationship. While some studies indicate periodontal treatment may improve glycemic control and reduce inflammation, overall evidence is inconsistent.
View Article and Find Full Text PDFIdentification of Known Flavonoids of Ficus carica L. as Aldose Reductase Inhibitors in Sciatic Nerve of Diabetic Neuropathy-induced Rats through Bioinformatics and Proteomics Analysis.
CNS Neurol Disord Drug Targets
March 2025
University Institute of Chemical Technology, KBC North Maharashtra University, Jalgaon 425001, MS, India.
Introduction: The polyol pathway is responsible for the metabolism of almost one-third of the total glucose in people with chronic diabetes. Moreover, it causes complications in organs that rely on aldose reductase (AR) as an enzyme. The purpose of this research was to examine the in vitro and in vivo effects of a flavonoid-rich ethyl acetate fraction of a methanolic extract of Ficus carica Lam.
View Article and Find Full Text PDFEffects of CXCR1/2 Blockade with Ladarixin on Streptozotocin-Induced Type 1 Diabetes Mellitus and Peripheral Neuropathy and Retinopathy in Rat.
Diabetes Metab J
March 2025
R&D, Dompé Farmaceutici SpA, L'Aquila, Italy.
Background: The CXC motif chemokine ligand 8 (CXCL8)-CXC motif chemokine receptor 1/2 (CXCR1/2) axis has been implicated in type 1 diabetes mellitus (T1DM). Its actions on non-immune cells may also contribute to T1DM-associated complications, including painful diabetic peripheral neuropathy (DPN) and diabetic retinopathy (DR).
Methods: We assessed the efficacy of early (4-8 weeks) or late (8-12 weeks) daily ladarixin (LDX) for the treatment of streptozotocin (STZ)-induced T1DM and the related complications of DPN or DR in male rats.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!